Name | Description | Industry | Official Website | Location | ||
---|---|---|---|---|---|---|
Mammoth Biosciences is an American company based in San Francisco founded on June 1, 2017. Mammoth Biosciences uses CRISPR technology to develop bio-sensing technologies for diagnostics in industries such as healthcare, agriculture, manufacturing, and forensics and genome editing therapeutics. | ||||||
Caribou Biosciences is a Berkeley, California—based private biopharmaceutical company founded in 2011 by Jennifer Doudna and Rachel Haurwitz. | ||||||
Intellia Therapeutics is a biotechnology company founded in 2014, based in Cambridge, MA that develops biopharmaceuticals using CRISPR-Cas9 gene editing technology. | ||||||
Scribe Therapeutics develops molecular engineering solutions for CRISPR-based genetic medicine. | ||||||
Editas Medicine is a genome editing company founded in 2013 that is using CRISPR technology to treat patients with genetically defined diseases. | ||||||
Mammoth Diagnostics is a Brisbane, California-based company founded in 2017 by Jennifer Doudna, Ashley Tehranchi, Trevor Martin, Janice Chen and Lucas Harrington. |